Author: OurCrowd

[HIL Medical in Globes] HIL Applied Medical acquires Nanolabz

Israeli company HIL Applied Medical, which develops laser-accelerated proton beams for medical purposes, has acquired US company Nanolabz. “The merger with Nanolabz makes it possible to combine the two companies’ patents and development teams, which complement each other, enabling us to accelerate our development,” says HIL Applied Medical CEO Sagi Brink-Danan. Following the merger, Nanolabz’s name will be changed to HIL US. The development center in the US will continue operating side by side with the Israeli development center, which will manage it. Read more on...

Read More

[HIL in Geektime] Israeli biomed HIL Applied Medical acquires Reno’s Nanolabz in race for cancer treatment

Jerusalem-based HIL Applied Medical Ltd. announced on Thursday their buyout of Nanolabz Inc., a Nevada-based firm developing smart nano-engineered targets for the short-pulse R&D sector. According to CEO Sagi Brink-Danan, HIL made their acquisition through an equity agreement wherein Nanolabz’s stakeholders gained ownership of 5% of the Israeli company’s shares. Read more on...

Read More

[HIL Press Release] Israeli startup HIL Applied Medical Ltd. acquires US-based Nanolabz Inc. – en route to developing advanced cancer radiotherapy systems

JERUSALEM and RENO, Nev., May 26, 2016 /PRNewswire/ — HIL Applied Medical Ltd. – a Jerusalem, Israel medical technology startup – has just announced the acquisition of Nanolabz Inc. – a Reno, Nevada company born out of University of Nevada, Reno research and focused on developing and fabricating smart targets for laser-based proton acceleration. HIL Applied Medical is developing a new class of ultra-compact, high-performance Proton Beam Therapy systems, based on high-intensity lasers and nano-engineered smart targetry. Read more on PR...

Read More

Fighting Goliath: 5 Innovative Cancer Technologies Establish New Ways to Beat the Deadly Disease

2016 is turning into a year of many changes in science and medicine, and nowhere is this more obvious than in the field of cancer research. In January, US President Obama announced a “moonshot” for cancer. “Let’s make America the country that cures cancer once and for all,” he said in his final State of the Union address, pledging to initiate a government-wide push to cure the disease as an analogy of the effort in the 1960s to send a man to the moon. The cancer moonshot is a $1B injection of cash focusing on new approaches. While the announcement of the president’s mission may have been somewhat unexpected, radical advances in science do provide new hope. Traditional approaches to the disease involve three main types of treatment for fighting cancer: surgery, chemotherapy, and radiation therapy. But today, cancer treatments are becoming more powerful, less toxic, and increasingly individualized — with researchers enlisting the help of the immune system in the body’s fight against cancer, and the emergence of new clinical trials and therapies. Here are some of today’s...

Read More